Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma
Abstract Background Cantharidin (CTD) is the active ingredient of Chinese medicine, which has been traditionally used in multiple cancers treatment, especially in hepatocellular carcinoma (HCC). However, a comprehensive analysis of the CTD-related molecular mechanism is still necessary to understand...
Main Authors: | Jia Yan, Yu min Gao, Xiu ling Deng, Hai sheng Wang, Gui tao Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-11-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-11594-8 |
Similar Items
-
Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response
by: Jia Yan, et al.
Published: (2023-05-01) -
Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention
by: Dian Jin, et al.
Published: (2023-06-01) -
Dual-Functional Liposomes with Carbonic Anhydrase IX Antibody and BR2 Peptide Modification Effectively Improve Intracellular Delivery of Cantharidin to Treat Orthotopic Hepatocellular Carcinoma Mice
by: Xue Zhang, et al.
Published: (2019-09-01) -
Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways
by: Faiza Naz, et al.
Published: (2020-07-01) -
Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma
by: Yilin Xu, et al.
Published: (2022-10-01)